Myriad Genetics, Inc.
Myriad Genetics, Inc. (MYGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MYGN · as of Jun 8, 2026
Key Statistics
Explore Myriad Genetics, Inc. Data
mygn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 36 · Buy rate: 22.2%
The MYGN analyst consensus is Hold, based on ratings from 36 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +34.83% upside from the current price of $4.45.
Competitors & Peers
mygn competitorsMYGN
AMN
CDNA
CSTL
DNA
DRIOStock Performance
Full HistoryAbout Myriad Genetics, Inc.
Myriad Genetics, Inc. a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tes…
what is myriad genetics, inc. · mygn stock overview · myriad genetics, inc. company profile · who is myriad genetics, inc. ceo · mygn NASDAQ · myriad genetics, inc. headquarters · myriad genetics, inc. business segments
About Stock Overview & Key Data
Myriad Genetics, Inc. (MYGN) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Oct 6, 1995. As of the latest trading session, MYGN stock price is $4.45, with a market capitalization of $420.3M. The stock has returned -12.62% over the past 12 months and -26.26% year-to-date.
According to 36 Wall Street analysts, the consensus rating for Myriad Genetics, Inc. stock is Hold, with an average 12-month price target of $6.00. In fiscal year 2025, Myriad Genetics, Inc. reported revenue of $824.5M and net income of -$365.9M. For detailed data — including Myriad Genetics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Myriad Genetics, Inc. (MYGN) stock price is $4.45. The stock is traded on NASDAQ under the ticker symbol MYGN. The 52-week range is $3.53 – $8.59.